DAM
ARKG icon

DLD Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

DLD Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-54,327
Closed -$1.51M – 381
2025
Q3 		$1.51M Buy
+54,327
New +$1.37M 0.11% 128

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

DLD Asset Management's ARKG Position: Q4 2025 in Review

DLD Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 54,327 shares — an estimated $1.51M sold.

DLD Asset Management first reported a position in ARKG in Q3 2025 and held it in 1 quarter. The position peaked at $1.51M in Q3 2025. 239 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

  • DLD Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
  • DLD Asset Management sold 54,327 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $1.51M.
  • DLD Asset Management first reported a position in ARK Genomic Revolution ETF in Q3 2025 and held it in 1 quarter.
  • DLD Asset Management's ARK Genomic Revolution ETF position peaked at $1.51M in Q3 2025.
  • 239 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on DLD Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.